Pharmaceutical Commerce

JANUARY 3, 2025

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

85

85

Pharmaceutical Technology

JANUARY 3, 2025

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel

Development 162

Development Research 162

Pharma Times

JANUARY 3, 2025

FDA gives green light to innovative device for liver conditions

FDA Approval 137

FDA Approval 137

Pharmaceutical Technology

JANUARY 3, 2025

Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses and clinical trials.

Clinical Trials 147

Clinical Trials Clinical Trials Trials 147

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Pharma Times

JANUARY 3, 2025

Government announces independent commission on social care

130

130

Pharmaceutical Technology

JANUARY 3, 2025

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

147

147

Pharmaceutical Technology

JANUARY 3, 2025

There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

Marketing 147

Marketing Development 147

Medical Xpress

JANUARY 3, 2025

Since its discovery in the 1990s, programmed cell death protein 1 (PD-1) has been regarded as a leading target in cancer treatments. A checkpoint receptor that often resides on the surface of immune system cells, the PD-1 molecule works as a type of "off" switch that keeps immune cells from attacking other cells.

Scientist 107

Scientist Protein 107

Pharmaceutical Technology

JANUARY 3, 2025

China NMPA has granted acceptance and priority review for the NDA for HUTCHMEDs ORPATHYS (savolitinib) and TAGRISSO (osimertinib) combination

147

147

pharmaphorum

JANUARY 3, 2025

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

105

105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Medical Xpress

JANUARY 3, 2025

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts in routine medical settings.

Doctors 105

Doctors Doctor 105

pharmaphorum

JANUARY 3, 2025

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.

FDA Approval 105

FDA Approval 105

Medical Xpress

JANUARY 3, 2025

A study from UCLA Health adds to the growing body of evidence on the cognitive benefits of speaking multiple languages, finding that multilingualism not only enhances general cognitive abilities but also may help reduce certain symptoms and bolster control of daily thoughts and actions in children with and without autism.

103

103

pharmaphorum

JANUARY 3, 2025

As we commence 2025, for those who are considered leaders or visionaries in their fields, its time to dust off the crystal ball and make some bold predictions about what this year will bring.

Life Science 98

Life Science 98

Advertisement

Clinical Supply

Medical Xpress

JANUARY 3, 2025

The COVID-19 pandemic highlighted how crucial testing is for disease preparedness and response, and new research from the Johns Hopkins Applied Physics Laboratory (APL) and a team of collaborators underscores that principle.

Research 100

Research 100

pharmaphorum

JANUARY 3, 2025

A five-step approach for optimising established brands' portfolio value Nicole.

Branding 98

Branding 98

Medical Xpress

JANUARY 3, 2025

A study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response.

Immune Response 97

Immune Response Regulation Research 97

pharmaphorum

JANUARY 3, 2025

Regeneron has bought Oxular, a UK specialist in retinal diseases, in a move that bolsters its already strong position in ophthalmology therapies.

95

95

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Medical Xpress

JANUARY 3, 2025

High-density lipoprotein (HDL), or "good" cholesterol, may play a vital role in conserving healthy brain matter in middle-aged adults, UT Southwestern Medical Center researchers report. The findings, published in the Journal of Clinical Medicine, could give doctors and patients more insight into factors that affect cognitive health in aging adults.

Doctors 92

Doctors Doctor Medicine Research 92

XTalks

JANUARY 3, 2025

The global market for eye drugs continues to grow as vision-related conditions, particularly among aging populations, drive demand for innovative therapies. Among the various treatments available, a few stand out as top performers, both for their clinical efficacy and commercial success. In this blog, we delve into the recent sales data to highlight the top three best-selling eye drugs in 2023.

Sales 85

Sales FDA Approval Drugs Medicine 85

Medical Xpress

JANUARY 3, 2025

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study by researchers at the National Institutes of Health (NIH) published today in Science.

Antibody 88

Antibody Research 88

pharmaphorum

JANUARY 3, 2025

As biotech start-ups evolve, the ability to communicate effectively with key stakeholders those who will fund the next stage of your journey becomes crucial.

Development 82

Development 82

Advertisement

Clinical Supply

Medical Xpress

JANUARY 3, 2025

Individuals with an autism spectrum disorder (ASD) diagnosis have an increased prevalence of identified dementia diagnoses, according to a research letter published online Jan. 2 in JAMA Network Open.

Research 85

Research 85

pharmaphorum

JANUARY 3, 2025

Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on corporate funding.

Research 75

Research 75

Medical Xpress

JANUARY 3, 2025

Researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine pioneered a first of its kind gene therapy model that offers a potential breakthrough in treating X-linked sideroblastic anemia (XLSA), a rare congenital anemia caused by mutations in the ALAS2 gene crucial for the synthesis of heme, a key compound in hemoglobin.

Gene Therapy 82

Gene Therapy Gene Medicine Research 82

Pharmaceutical Commerce

JANUARY 3, 2025

The latest news for pharma industry insiders.

59

59

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Medical Xpress

JANUARY 3, 2025

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Hormones 81

Hormones Research 81

Pharmaceutical Commerce

JANUARY 3, 2025

In the final part of this roundtable discussion, a panel of subject matter experts discuss what the future holds for this technology, why end-to-end visibility is necessary in healthcare, and the opportunities for greater RFID adoption that lie ahead.

52

52

Medical Xpress

JANUARY 3, 2025

The global dietary supplements market, valued at $178.8 billion in 2023, is rapidly growing. UC Davis Health molecular exercise physiologist Keith Baar specializes in sports medicine and studies the effects of collagen, whey and omega-3 supplements on bone and tendon health.

Medicine 80

Medicine Marketing 80

pharmaphorum

JANUARY 3, 2025

The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.

52

52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research